Mastering Immunity Europe 2019

Thursday 21 March 2019, Wolfson College, Oxford, UK
Register today

Filmed Presentations from all our meetings are available online

Join our Mastering Immunogenicity LinkedIn Group

Understand and manage immune responses in drug and vaccine development

As targeted immune therapies grow in complexity, understanding and controlling immune regulation has never been more important in the design of therapeutics.

Join experts in both academic and commercial immunology at Mastering Immunity Europe 2019 for a focussed conference to learn the latest developments in this fast-developing field covering multiple aspects of in the development of modern therapeutics. This focussed meeting is a forum for key people involved in wanting to characterize immune modulation following delivery of biologics and other therapies to come together to share knowledge, perspectives and discuss solutions to the complex challenges of immunity in this context. We will focus on manipulation and characterization of both desired (in immuno-oncology and vaccines) as well as unwanted immune responses (i.e. immunogenicity to biotherapeutics or viral vectors).

This meeting in Oxford, is now in its seventh consecutive year having also been held in Cambridge, MA. It offers an unparalleled opportunity to meet are share information with like-minded scientists from other organisations, and to help shape the future of your R&D programs.


08.30Registration opens / coffee
09.05Dr. Jonathan Silk, Adaptimmune, OxfordNext Generation approaches to enhance the efficacy of SPEAR T-cells
09.30Prof. Yaohe Wang, Barts Cancer Institute, LondonA new prophylactic cancer vaccine platform for prevention of development of pancreatic and lung cancer
09.55Dr. Marie Toussaint, GSK Vaccines, BelgiumHow to develop the vaccines of tomorrow?
10.20Dr. Margot El-Khouri, ProImmune, OxfordEpitope identification and clinical immune monitoring in immune oncology programs
10.50Coffee and networking
11.30Dr. Lucy Dorrell, Immunocore, OxfordImmune-mobilising monoclonal T cell receptors for elimination of chronic viral and bacterial infections
11.55Dr. Laura Meulenbroek, Danone Nutricia Research, The NetherlandsIdentification of Peptides with Tolerogenic Potential in a Hydrolyzed Whey-Based Infant Formula
12.30Dr. Christos Georgiadis, Institute of Child Health, LondonCoupled Long Terminal-CRISPR Gene Editing for the Redirection of T cells
14.00Dr. Jeremy Fry, ProImmune, OxfordAn Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design
14.30Mr. Clemens Joos, Helmholtz Centre Munich, GermanyGene transfer of MHC II-restricted CMV-specific TCRs for development of immunotherapy
14.55Dr. Laurent Vidard, Sanofi, Franceartificial Antigen Presenting Cells (aAPCs) to decipher the mechanisms leading to immune cells proliferation and activation
15.20Coffee and networking
15.50Dr. Stefania Capone, ReiThera, ItalyChimpanzee Adenoviral vectors: a potent and flexible platform for genetic vaccination
16.25Dr. Tom Evans, Vaccitech, OxfordHeterologous prime-boost approaches to CD8+ T cell induction
16.50Dr. Guillaume Dorothee, Hopital Saint Antoine, FranceT-cell immunity in Alzheimer’s disease : role in the pathophysiology and therapeutic opportunities
17.15Networking Drinks

 How will I benefit?



  • Learn the key issues facing drug developers
  • Be informed of the latest strategies for preclinical and clinical immune modulation
  • Quality by Design in drug development
  • Be informed of the latest strategies for pre-clinical and clinical immune modulation
  • Case studies
    • Exchange new ideas
    • Meet potential collaborators
    • Discuss current and developing challenges
  • Meet like-minded scientists from other organizations, and to help shape the future of your own R&D programs.

Feedback from previous conferences:

“Mastering Immunogenicity captured the breadth and depth of immunogenicity issues faced by industry today” (Tim Hickling, Pfizer)

“I absolutely enjoyed the talks and very much liked the small and highly interactive fomat of the meeting. The quality of the program was very high and I indeed picked up some useful ideas that I am incorporating into our programs.” (Shahla Abodollahi, Celgene)

“It has been a terrific opportunity to learn more about immunology, and immunogenicity in particular, from esteemed colleagues in the field, interacting with them and sharing some of my views on the topic. I look forward to more of these.” (Andrea Ferrante, Eli Lilly)

“I also had a great time during the meeting. It was truly excellent in content and organization.” (Julio Delgado, University of Utah)

“It was a terrific event, with excellent speakers and great networking/brainstorming opportunities at the breaks and with the roundtable” (Valerie Quarmby, Genentech)

“Great first experience. I enjoyed the breadth of topics” (Laurent Malherbe, Eli Lilly)

“Great speakers with diverse topics. I enjoyed the deep science and also the opinions from experts in the field” (Xiaoying Chen, Pfizer)

“Covered a diverse array of subjects. I enjoyed the networking opportunities” (Shinu John, Moderna Therapeutics)

“Excellent event” (George Gunn, Janssen R&D)

“Really liked the interactive environment. In-depth discussions with very relevant colleagues”

 “I really enjoyed the very good quality, sparkling diversity, but still keeping focus”

“Very nice and comprehensive topics in this symposium. I have learnt a lot from it.” (Pu Shi, Takeda)

“This is a fantastic conference that is a good mix of vaccine and biotherapeutic folks. Facilitates learning and collaboration.” (Priya Sriraman, Celgene)

Conference Venue

The City of Oxford

Picture: Nasir Hamid

A fitting venue for our conference, Oxford is a world leading centre in science research and education.

Situated approximately 50 miles north-west of London, modern Oxford owes much to the University, which was founded in 1096 and is the oldest university in the English speaking world. Visitors to the city can tour splendid British architecture, including such icons as the mid-18th century Radcliffe Camera, the Bodleian Library and the Bridge of Sighs.

For further information about Oxford and the surrounding area browse, “Experience Oxfordshire”, the official tourism website for Oxfordshire.

Wolfson College

Wolfson College, part of the University of Oxford, is situated within 13 acres of stunning riverside gardens. It offers a tranquil rural retreat just a short walk from Oxford city centre. Wolfson is an all-graduate college with students from 75 nations. It was founded in 1965 by Sir Isaiah Berlin, the influential political philosopher.
The conference itself will take place in Wolfson’s award-winning Leonard Wolfson Auditorium.  This building is very striking architecturally, with a remarkably shaped ceiling giving excellent acoustics, and chestnut-lined interior creating a sense of elegance and light.

Although no accommodation is available at the college, we would recommend the following establishments just a short distance away:

The Best Western Linton Lodge Hotel: (2 minute walk)
Parklands Bed & Breakfast: (5 minute walk)
Cotswold Lodge (10 minute walk)

Oxford is 56 miles (90km) north-west of London, with excellent bus and rail services.

By Air
There are 3 major international airports (London Heathrow, LHR; London Gatwick, LGW; Birmingham International, BHX) within 2 hours travel time. The simplest and best option if you are flying to any of these airports is to take the regular bus service direct to Oxford City. See  for details. Airport Taxi Transfers: Pryors (+44 1235 812346).

By Road
The city is well served by public transport but the historic nature of the city center means parking spaces are in very short supply. There is no parking available at the conference venue. We would recommend parking at the Water Eaton Park and Ride or Peartree Park and Ride. Both are just a 15-20 minute bus ride to the conference.

By Rail
The closest rail stations are Oxford (serving direct trains from London Paddington) and Oxford Parkway (serving direct trains from London Marylebone). Both stations are a 15-20 minute direct bus ride / 10 minute taxi ride from the venue. See for more details.

For all Conference Enquiries please contact:

Telephone (toll free): USA & Canada +1 888 505 7765
All other countries +44 (0) 870 042 7279